Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001928327 | SCV002181280 | uncertain significance | Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH | 2025-01-28 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 281 of the BAG3 protein (p.Ala281Thr). This variant is present in population databases (no rsID available, gnomAD 0.002%). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 28416588). ClinVar contains an entry for this variant (Variation ID: 1413809). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt BAG3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004996103 | SCV005540438 | uncertain significance | Cardiovascular phenotype | 2024-07-22 | criteria provided, single submitter | clinical testing | The p.A281T variant (also known as c.841G>A), located in coding exon 3 of the BAG3 gene, results from a G to A substitution at nucleotide position 841. The alanine at codon 281 is replaced by threonine, an amino acid with similar properties. This variant has been detected in dilated cardiomyopathy cohorts; however, details were limited (Dal Ferro M et al. Heart, 2017 Nov;103:1704-1710; Perret C et al. Clin Genet, 2024 Feb;105:185-189). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |